Tag: lymphoma

Their experience shifted career goals toward Wilmot patients.

A treatment that rallies the immune system to destroy cancer raised the survival rate for advanced Hodgkin lymphoma patients to a remarkable 92 percent, suggesting a new standard therapy for the ...

Stem cell transplants can help ensure remission for some cancer patients, but many of these patients experience a side effect known as chronic graft-versus-host disease (cGVHD). Nurse-researchers at ...

It was college spring break week at the University of Rochester in 1976 for John Saunders, but there would be no fun outings, no hanging out. He had just learned he had Hodgkin lymphoma. He shares ...

The latest edition of Dialogue magazine from the Wilmot Cancer Institute is about progress, gratitude, and achievement, as the cancer center reaches its 50-year milestone.

Get to know Jamie Flerlage, MD, MS. She recently joined URMC as the new Chief and Academic Director of Pediatric Hematology/Oncology at Golisano Children's Hospital and Assistant Director of Clinical ...

From basic science to communications tools for cancer patients, Wilmot researchers are making an impact.

Thanks to a groundbreaking nationwide study with Wilmot Director Jonathan Friedberg at the helm, a practice-changing treatment emerged for young people with Hodgkin lymphoma.

In a new study, the majority of individuals treated as children for Hodgkin lymphoma who are now in their 30s, showed signs of being an average of 7.7 years older biologically than their peers.

Two major clinical trials are changing the landscape in the most common form of lymphoma.